HPV Screening (Human Papilloma Virus)

Clinical Trial Description

500 females attending colposcopy kasrelaini unit are included. History including age and parity is taken.urine samples are taken. Colposcopy will be done. Pap smear will be taken and sent for pathology. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

HPV Testing

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05727228` - Screening Triage and Risk Stratification
	Recruiting	`NCT02155231` - Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand

See also

Status

Clinical Trial

Phase

Recruiting

NCT05727228 - Screening Triage and Risk Stratification

Recruiting

NCT02155231 - Study on Anal Human Papillomavirus Infection and Anal Intraepithelial Neoplasia Among Men Who Have Sex With Men in Indonesia, Malaysia, and Thailand

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02613611
Study type	Observational
Source	Kasr El Aini Hospital
Contact
Status	Not yet recruiting
Phase	N/A
Start date	November 2015
Completion date	March 2016

HPV Screening (Human Papilloma Virus) — HPV

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms